Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-19-055866

Director sold 6,000 shares at an average $38.27 ($229,624)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kurkijarvi Kalevi · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-07 Exercise or conversion : show line 1 in the form +6,000 $9.78 $58,650 34,400 D
2019-11-07 Sale : show line 2 in the form −4,514 $38.08 $171,893 29,886 D
2019-11-07 Sale : show line 3 in the form −1,486 $38.85 $57,731 28,400 D
Open-market sales · 6,000 sh · avg $38.27 · $229,624

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-11-07 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,000 $9.78 2023-04-17 6,000 0 D
Loading xslF345X03/doc4.xml…